Zhejiang Chimin Pharmaceutical Co.,Ltd provided earnings guidance for the first half of 2017. For the first half, the company expects the net profit belonging to shareholders will be between RMB 19.23 million and RMB 20.51 million, with an increase of between 50% and 60% compared with the same period of the year before.